Arteriovenous fistula occlusion
Also known as: Arteriovenous fistula occlusion (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00086 | Streptokinase | A purified fibrinolytic bacterial protein used to breakdown thrombosis in myocardial infarction, pulmonary embolism, and venous thromboembolism. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00086 | Streptokinase | Plasminogen | target |
| DB00086 | Streptokinase | Proteinase-activated receptor 1 | target |
| DB00086 | Streptokinase | Cytosolic phospholipase A2 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00126 | Ascorbic acid | 2 | Unknown Status | 1 |
| DB00859 | Penicillamine | 2 | Unknown Status | 1 |